The evolvement of definition and nomenclature in bronchopulmonary dysplasia and advances in its treatment
10.3760/cma.j.issn.1673-4912.2016.12.001
- VernacularTitle:支气管肺发育不良定义和命名的演变与治疗进展
- Author:
Liwen CHANG
- Keywords:
Bronchopulmonary dysplasia;
Chronic lung disease;
Definition;
Nomenclature;
Treat-ment
- From:
Chinese Pediatric Emergency Medicine
2016;23(12):801-804
- CountryChina
- Language:Chinese
-
Abstract:
Bronchopulmonary dysplasia ( BPD) ,also called chronic lung disease ( CLD) ,is a com-mon respiratory disease of premature infants. It was first reported and named by Northway et al, carrying unique etiology,pathology and clinical features. BPD reported by Northway is referred as old or classic BPD. Manifestations and prognosis of premature infants with respiratory diseases have been improved significantly after evolutional changes by applying glucocorticoid and exogenous surfactant,as well as protective ventilator protocols after birth. Nowadays,incidents of severe BPD described by Northway are extremely low,whereas mild BPD,also called ‘new’ BPD,is much more common. Definition and nomenclature of BPD have been controversial since first being brought out in 1967. This article was focused on the definition and nomenclature and current advances in BPD treatment.
